Legalizes adult possession and use of certain natural plant or fungus-based hallucinogens; grants certain protections for individuals lawfully using such hallucinogens; removes such hallucinogens from the list of schedule I controlled substances; makes related provisions.
Summary
Bill A00628 seeks to legalize the possession and use of certain natural plant or fungus-based hallucinogens for adults aged 21 and older in the state of New York. The bill defines specific substances, including Dimethyltryptamine (DMT), Ibogaine, Mescaline, Psilocybin, and Psilocyn, and outlines authorized activities such as cultivation, production, and sharing of these substances. It also provides protections for individuals using these hallucinogens, ensuring that their conduct cannot be deemed criminal under state law and that they are not subject to penalties or loss of professional licenses for personal use.
Additionally, the bill amends existing laws to remove these hallucinogens from the list of Schedule I controlled substances, thereby aligning state law with the new provisions. It allows local municipalities to enact their own regulations regarding the use of these substances, fostering a decentralized approach to the implementation of the law. The bill also includes provisions to protect individuals from discrimination in employment and access to services based on their lawful use of hallucinogens.
The impact of this legislation would be significant, as it not only alters the legal status of certain hallucinogens but also establishes a framework for their regulated use. This could lead to changes in law enforcement practices, as local agencies would be restricted from cooperating with federal enforcement regarding these substances. Furthermore, the bill aims to address public health considerations by allowing for the provision of supportive services for individuals using hallucinogens in a controlled and safe manner.
Impact
The passage of Bill A00628 would fundamentally change the legal landscape surrounding natural plant or fungus-based hallucinogens in New York. By legalizing their possession and use for adults, the bill removes these substances from the state's Schedule I controlled substances list, which could lead to reduced criminal penalties and law enforcement actions related to these substances. This shift may also influence public health policies and practices, as mental health and substance use disorder services could incorporate hallucinogen-related therapies without fear of legal repercussions. Additionally, the bill's provisions for local municipalities to regulate these substances may result in a patchwork of laws across the state, affecting how these substances are treated in different jurisdictions.
Sentiment
The sentiment surrounding Bill A00628 appears to be mixed based on the discussions and lack of voting history. Proponents argue that the legalization of natural hallucinogens can lead to therapeutic benefits and personal freedoms, while opponents may express concerns about public safety, potential misuse, and the implications of aligning state law with substances that remain illegal federally. The absence of recorded votes suggests that the bill may still be under consideration or facing opposition, indicating that further debate is likely needed before any final decision is made.
Contention
Notable points of contention regarding Bill A00628 include concerns about the potential for increased substance misuse and the implications for public health and safety. Opponents may argue that legalizing hallucinogens could lead to negative societal impacts, including increased access to these substances by minors or those with mental health issues. Additionally, there may be apprehensions regarding the federal-state conflict, as these substances remain illegal under federal law. Proponents, on the other hand, emphasize the therapeutic potential of these substances and the importance of personal autonomy in their use, advocating for a regulated approach to their legalization.
Legalizes adult possession and use of certain natural plant or fungus-based hallucinogens; grants certain protections for individuals lawfully using such hallucinogens; removes such hallucinogens from the list of schedule I controlled substances; makes related provisions.
Establishes the presence of a controlled substance in open view in a room, other than a public place, under certain circumstances is presumptive evidence of knowing possession thereof by each and every person present in such room in close proximity to such controlled substance at the time such controlled substance was found.
Establishes certain offenses based on homicide due to criminal sale of a controlled substance; establishes the offense of criminal sale of a controlled substance to a child in the first degree; expands the definition of controlled substances with respect to certain offenses; increases the felony classification of certain controlled substance offenses; includes electronic prescriptions and blank prescription forms in the definition of certain controlled substance offenses.
Relates to the scheduling of a fact finding hearing after the issuance of a temporary order of protection in family court; provides that such hearing shall be scheduled no later than 14 days after the temporary order is issued.
Relates to granting certain individuals youthful offender status; adds a new category of individuals eligible for young adult offender status; provides for process and sentencing requirements related to such statuses.
Relates to controlled substances and indeterminate sentences; relates to the expansion of merit time; repeals provisions relating to the allowance of limited credit time for incarcerated individuals.
Relating to adding certain substances to the Texas Controlled Substances Act and regulating kratom and kratom products; increasing civil penalties; creating criminal offenses; increasing a criminal penalty.
Expands implied consent law to include blood testing; establishes per se standard for driving under influence of marijuana and certain controlled dangerous substances.
Expands implied consent law to include blood testing; establishes per se standard for driving under influence of marijuana and certain controlled dangerous substances.